Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Feb;28(2):391–392. doi: 10.1128/jcm.28.2.391-392.1990

Pyrazinamidase activity as a phenotypic marker for several Aeromonas spp. isolated from clinical specimens.

A Carnahan 1, L Hammontree 1, L Bourgeois 1, S W Joseph 1
PMCID: PMC269619  PMID: 2312687

Abstract

Negative pyrazinamidase activity was significantly associated with Aeromonas sobria, and positive pyrazinamidase activity was associated with A. hydrophila and A. caviae (chi 2, P less than 0.0001). The absence of pyrazinamidase activity may be a potentially significant phenotypic marker for A. sobria.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daily O. P., Joseph S. W., Coolbaugh J. C., Walker R. I., Merrell B. R., Rollins D. M., Seidler R. J., Colwell R. R., Lissner C. R. Association of Aeromonas sobria with human infection. J Clin Microbiol. 1981 Apr;13(4):769–777. doi: 10.1128/jcm.13.4.769-777.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Janda J. M. Biochemical and exoenzymatic properties of Aeromonas species. Diagn Microbiol Infect Dis. 1985 May;3(3):223–232. doi: 10.1016/0732-8893(85)90034-3. [DOI] [PubMed] [Google Scholar]
  3. Janda J. M., Brenden R. Importance of Aeromonas sobria in Aeromonas bacteremia. J Infect Dis. 1987 Mar;155(3):589–591. doi: 10.1093/infdis/155.3.589. [DOI] [PubMed] [Google Scholar]
  4. Janda J. M., Duffey P. S. Mesophilic aeromonads in human disease: current taxonomy, laboratory identification, and infectious disease spectrum. Rev Infect Dis. 1988 Sep-Oct;10(5):980–997. doi: 10.1093/clinids/10.5.980. [DOI] [PubMed] [Google Scholar]
  5. Janda J. M., Reitano M., Bottone E. J. Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum. J Clin Microbiol. 1984 Jan;19(1):44–47. doi: 10.1128/jcm.19.1.44-47.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kandolo K., Wauters G. Pyrazinamidase activity in Yersinia enterocolitica and related organisms. J Clin Microbiol. 1985 Jun;21(6):980–982. doi: 10.1128/jcm.21.6.980-982.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Konno K., Feldmann F. M., McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 1967 Mar;95(3):461–469. doi: 10.1164/arrd.1967.95.3.461. [DOI] [PubMed] [Google Scholar]
  8. Kuijper E. J., Steigerwalt A. G., Schoenmakers B. S., Peeters M. F., Zanen H. C., Brenner D. J. Phenotypic characterization and DNA relatedness in human fecal isolates of Aeromonas spp. J Clin Microbiol. 1989 Jan;27(1):132–138. doi: 10.1128/jcm.27.1.132-138.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tsukamura M. Numerical analysis of the taxonomy of Nocardiae and Rhodococci. Microbiol Immunol. 1982;26(12):1101–1119. doi: 10.1111/j.1348-0421.1982.tb00260.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES